Cairo – Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO) reported consolidated net profits of EGP 358.69 million in the first nine months of 2021, up by 5.6% year-on-year (YoY) from EGP 339.46 million, including minority shareholders' rights.
The net sales increased to EGP 2.48 billion in the January-September period of 2021, compared to EGP 2.16 billion in the prior-year period, the company said in a bourse disclosure on Sunday.
As for standalone business, the company posted net profits of EGP 326.03 million in the nine-month period ended 30 September, up from EGP 281.51 million in the corresponding period a year earlier.
In the first half (H1) of 2021, EIPICO achieved consolidated net profits of EGP 270.76 million, slightly up from EGP 262.2 million in H1-20.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2021 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
